This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Bioscore
days left
7
66%
Raised
£53,220
Investors
61
Target
£80,000
Equity
5.06%
Pre-money valuation
£1,500,000

BioScore is on a mission to make health and fitness reporting digital, simple and visual. Its infographics for health and fitness aim to tell an inspiring story by contextualising data with reference ranges, colour codes, targets, benchmarks, linked test histories and more.

  • High growth health & fitness sector; UK fitness industry valued £5bn
  • Experienced founder with exit experience. Last exit 23X share price
  • Proof of concept is built and ready to demonstrate
  • Looking to target 7200 gyms with over 10m members in the UK

Idea

Health reports can be confusing. Medical results use acronyms like HbA1C & CRP and fitness results quote scores for VO2Max and LTHR, often without context or links to test histories.

Bioscore aims to be a B2B technology platform that powers the health, fitness, sports and wellness sectors through simple and engaging digital reporting.

We aim to leverage the trend of health optimisation; consumers want to understand their health, measure it, improve it. Our infographics contextualise health data with reference ranges, colour codes, targets, benchmarks, linked test histories and more.

For health and fitness professionals, Bioscore will build their connection with clients. For the end-user, our platform will provide meaningful infographics, simple explanations, linked test histories and personalised advice and action plans from their coach or health professionals.

Our vision is to develop a leading athlete management platform with inspiring infographics and rich reporting as its core USP. We plan to sell licences to access our suite of online tools.

We've built the technical architecture, our proof of concept is live and we believe we are in a position to move quickly to first revenues following this capital raise.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Bioscore pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered? Log in

This pitch is approved by Crowdcube

This pitch is approved as a financial promotion by Crowdcube Capital Limited. Every pitch on Crowdcube is reviewed to ensure it is fair, clear and not misleading.

As part of our commitment to investor transparency, Crowdcube’s Due Diligence Charter outlines the analysis and verification that is conducted on equity fundraises on Crowdcube by our legal and compliance professionals.

Read more

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Bioscore has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.